Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1983 May;59(691):277–282. doi: 10.1136/pgmj.59.691.277

Recent advances in pancreatic hormone research.

R G Long
PMCID: PMC2417418  PMID: 6136029

Full text

PDF
277

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adrian T. E., Barnes A. J., Long R. G., O'Shaughnessy D. J., Brown M. R., Rivier J., Vale W., Blackburn A. M., Bloom S. R. The effect of somatostatin analogs on secretion of growth, pancreatic, and gastrointestinal hormones in man. J Clin Endocrinol Metab. 1981 Oct;53(4):675–681. doi: 10.1210/jcem-53-4-675. [DOI] [PubMed] [Google Scholar]
  2. Adrian T. E., Besterman H. S., Mallinson C. N., Garalotis C., Bloom S. R. Impaired pancreatic polypeptide release in chronic pancreatitis with steatorrhoea. Gut. 1979 Feb;20(2):98–101. doi: 10.1136/gut.20.2.98. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Adrian T. E., McKiernan J., Johnstone D. I., Hiller E. J., Vyas H., Sarson D. L., Bloom S. R. Hormonal abnormalities of the pancreas and gut in cystic fibrosis. Gastroenterology. 1980 Sep;79(3):460–465. [PubMed] [Google Scholar]
  4. Barnes A. J., Long R. G., Adrian T. E., Vale W., Brown M. R., Rivier J. E., Hanley J., Ghatei M. A., Sarson D. L., Bloom S. R. Effect of a long-acting octapeptide analogue of somatostatin on growth hormone and pancreatic and gastrointestinal hormones in man. Clin Sci (Lond) 1981 Nov;61(5):653–656. doi: 10.1042/cs0610653. [DOI] [PubMed] [Google Scholar]
  5. Bloom S. R., Adrian T. E., Barnes A. J., Polak J. M. Autoimmunity in diabetics induced by hormonal contaminants of insulin. Lancet. 1979 Jan 6;1(8106):14–17. doi: 10.1016/s0140-6736(79)90455-0. [DOI] [PubMed] [Google Scholar]
  6. Boden G., Reichard G. A., Jr, Hoeldtke R. D., Rezvani I., Owen O. E. Severe insulin-induced hypoglycemia associated with deficiencies in the release of counterregulatory hormones. N Engl J Med. 1981 Nov 12;305(20):1200–1205. doi: 10.1056/NEJM198111123052007. [DOI] [PubMed] [Google Scholar]
  7. Bosch J., Kravetz D., Rodes J. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin. Gastroenterology. 1981 Mar;80(3):518–525. [PubMed] [Google Scholar]
  8. Dawson J., Bloom S. R., Cockel R. A unique apudoma producing the glucagonoma and gastrinoma syndromes. Postgrad Med J. 1983 May;59(691):315–316. doi: 10.1136/pgmj.59.691.315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dharmsathaphorn K., Sherwin R. S., Cataland S., Jaffe B., Dobbins J. Somatostatin inhibits diarrhea in the carcinoid syndrome. Ann Intern Med. 1980 Jan;92(1):68–69. doi: 10.7326/0003-4819-92-1-68. [DOI] [PubMed] [Google Scholar]
  10. Fahrenkrug J., Schaffalitzky de Muckadell O. B., Holst J. J., Jensen S. L. Vasoactive intestinal polypeptide in vagally mediated pancreatic secretion of fluid and HCO3. Am J Physiol. 1979 Dec;237(6):E535–E540. doi: 10.1152/ajpendo.1979.237.6.E535. [DOI] [PubMed] [Google Scholar]
  11. Frölich J. C., Bloomgarden Z. T., Oates J. A., McGuigan J. E., Rabinowitz D. The carcinoid flush. Provocation by pentagastrin and inhibition by somatostatin. N Engl J Med. 1978 Nov 9;299(19):1055–1057. doi: 10.1056/NEJM197811092991908. [DOI] [PubMed] [Google Scholar]
  12. Gerich J. E., Patton G. S. Somatostatin. Physiology and clinical applications. Med Clin North Am. 1978 Mar;62(2):375–392. doi: 10.1016/s0025-7125(16)31813-2. [DOI] [PubMed] [Google Scholar]
  13. Greenberg G. R., McCloy R. F., Adrian T. E., Chadwick V. S., Baron J. H., Bloom S. R. Inhibition of pancreas and gallbladder by pancreatic polypeptide. Lancet. 1978 Dec 16;2(8103):1280–1282. doi: 10.1016/s0140-6736(78)92042-1. [DOI] [PubMed] [Google Scholar]
  14. Hirsch H. J., Loo S., Evans N., Crigler J. F., Filler R. M., Gabbay K. H. Hypoglycemia of infancy and nesidioblastosis. Studies with somatostatin. N Engl J Med. 1977 Jun 9;296(23):1323–1326. doi: 10.1056/NEJM197706092962305. [DOI] [PubMed] [Google Scholar]
  15. Kayasseh L., Gyr K., Keller U., Stalder G. A., Wall M. Somatostatin and cimetidine in peptic-ulcer haemorrhage. A randomised controlled trial. Lancet. 1980 Apr 19;1(8173):844–846. doi: 10.1016/s0140-6736(80)91352-5. [DOI] [PubMed] [Google Scholar]
  16. Kirkegaard P., Moody A. J., Holst J. J., Loud F. B., Olsen P. S., Christiansen J. Glicentin inhibits gastric acid secretion in the rat. Nature. 1982 May 13;297(5862):156–157. doi: 10.1038/297156a0. [DOI] [PubMed] [Google Scholar]
  17. Krarup T., Schwartz T. W., Hilsted J., Madsbad S., Verlaege O., Sestoft L. Impaired response of pancreatic polypeptide to hypoglycaemia: an early sign of autonomic neuropathy in diabetics. Br Med J. 1979 Dec 15;2(6204):1544–1546. doi: 10.1136/bmj.2.6204.1544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Krejs G. J., Orci L., Conlon J. M., Ravazzola M., Davis G. R., Raskin P., Collins S. M., McCarthy D. M., Baetens D., Rubenstein A. Somatostatinoma syndrome. Biochemical, morphologic and clinical features. N Engl J Med. 1979 Aug 9;301(6):285–292. doi: 10.1056/NEJM197908093010601. [DOI] [PubMed] [Google Scholar]
  19. Long R. G., Albuquerque R. H., Prata A., Barnes A. J., Adrian T. E., Christofides N. D., Bloom S. R. Response of plasma pancreatic and gastrointestinal hormones and growth hormone to oral and intravenous glucose and insulin hypoglycaemia in Chagas's disease. Gut. 1980 Sep;21(9):772–777. doi: 10.1136/gut.21.9.772. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Long R. G., Barnes A. J., Adrian T. E., Mallinson C. N., Brown M. R., Vale W., Rivier J. E., Christofides N. D., Bloom S. R. Suppression of pancreatic endocrine tumour secretion by long-acting somatostatin analogue. Lancet. 1979 Oct 13;2(8146):764–767. doi: 10.1016/s0140-6736(79)92115-9. [DOI] [PubMed] [Google Scholar]
  21. Long R. G., Bryant M. G., Yuille P. M., Polak J. M., Bloom S. R. Mixed pancreatic apudoma with symptoms of excess vasoactive intestinal polypeptide and insulin: improvement of diarrhoea with metoclopramide. Gut. 1981 Jun;22(6):505–511. doi: 10.1136/gut.22.6.505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lundbaek K., Hansen A. P., Orskov H., Christensen S. E., Iversen J., Seyer-Hansen K., Alberti K. G., Whitefoot R. Failure of somatostatin to correct manifest diabetic ketoacidosis. Lancet. 1976 Jan 31;1(7953):215–218. doi: 10.1016/s0140-6736(76)91338-6. [DOI] [PubMed] [Google Scholar]
  23. Mallinson C. N., Bloom S. R., Warin A. P., Salmon P. R., Cox B. A glucagonoma syndrome. Lancet. 1974 Jul 6;2(7871):1–5. doi: 10.1016/s0140-6736(74)91343-9. [DOI] [PubMed] [Google Scholar]
  24. Manche A., Wood S. M., Adrian T. E., Welbourn R. B., Bloom S. R. Pancreatic polypeptide and calcitonin secretion from a pancreatic tumour-clinical improvement after hepatic artery embolization. Postgrad Med J. 1983 May;59(691):313–314. doi: 10.1136/pgmj.59.691.313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. McCarthy D. M. The place of surgery in the Zollinger-Ellison syndrome. N Engl J Med. 1980 Jun 12;302(24):1344–1347. doi: 10.1056/NEJM198006123022404. [DOI] [PubMed] [Google Scholar]
  26. Moertel C. G., Hanley J. A., Johnson L. A. Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet-cell carcinoma. N Engl J Med. 1980 Nov 20;303(21):1189–1194. doi: 10.1056/NEJM198011203032101. [DOI] [PubMed] [Google Scholar]
  27. Moody A. J., Holst J. J., Thim L., Jensen S. L. Relationship of glicentin to proglucagon and glucagon in the porcine pancreas. Nature. 1981 Feb 5;289(5797):514–516. doi: 10.1038/289514a0. [DOI] [PubMed] [Google Scholar]
  28. Polak J. M., Bloom S. R., Adrian T. E., Heitz P., Bryant M. G., Pearse A. G. Pancreatic polypeptide in insulinomas, gastrinomas, vipomas, and glucagonomas. Lancet. 1976 Feb 14;1(7955):328–330. doi: 10.1016/s0140-6736(76)90084-2. [DOI] [PubMed] [Google Scholar]
  29. Sonnenberg G. E., Keller U., Perruchoud A., Burckhardt D., Gyr K. Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjects. Gastroenterology. 1981 Mar;80(3):526–532. [PubMed] [Google Scholar]
  30. Tamborlane W. V., Sherwin R. S., Hendler R., Felig P. Metabolic effects of somatostatin in maturity-onset diabetes. N Engl J Med. 1977 Jul 28;297(4):181–183. doi: 10.1056/NEJM197707282970403. [DOI] [PubMed] [Google Scholar]
  31. Tannenbaum G. S., Colle E. Ineffectiveness of protamine zinc somatostatin as a long-acting inhibitor of insulin and growth hormone secretion. Can J Physiol Pharmacol. 1980 Aug;58(8):951–955. doi: 10.1139/y80-145. [DOI] [PubMed] [Google Scholar]
  32. Thim L., Moody A. J. The primary structure of porcine glicentin (proglucagon). Regul Pept. 1981 May;2(2):139–150. doi: 10.1016/0167-0115(81)90007-0. [DOI] [PubMed] [Google Scholar]
  33. Thulin L., Tydén G., Samnegård H., Muhrbeck O., Efendić S. Treatment of bleeding oesophageal varices with somatostatin. Acta Chir Scand. 1979;145(6):395–398. [PubMed] [Google Scholar]
  34. Valenzuela J. E., Taylor I. L., Walsh J. H. Pancreatic polypeptide response in patients with chronic pancreatitis. Dig Dis Sci. 1979 Nov;24(11):862–864. doi: 10.1007/BF01324903. [DOI] [PubMed] [Google Scholar]
  35. Wass J. A., Penman E., Dryburgh J. R., Tsiolakis D., Goldberg P. L., Dawson A. M., Besser G. M., Rees L. H. Circulating somatostatin after food and glucose in man. Clin Endocrinol (Oxf) 1980 Jun;12(6):569–574. doi: 10.1111/j.1365-2265.1980.tb01377.x. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES